Doruk Erkan, MD, MPH

If your insurance is not listed, please call our office if you have questions regarding your insurance coverage. If you have out-of-network benefits, then your insurance may reimburse you for a portion of your office visit. We will work with you and your insurance to minimize your out-of-pocket costs. Financial assistance may be available for patients in need.

Appointments

Affiliations

American College of Rheumatology, Fellow
New York Rheumatism Association, Executive Committee
APS ACTION, Executive Committee Chair

Certification

American Board of Rheumatology, 2001, 2011
American Board of Internal Medicine, 1999, 2009
Certificate in Clinical Epidemiology and Health Services Research, Weill Cornell Medical College, 2000

Awards

Castle Connolly Top Doctor - 5 Years
Castle Connolly Top Doctors in New York Metro Area, 2016-2022
Castle Connolly Regional Top Doctor, 2015-2020
New York Magazine Top Doctors, 2021, 2022
R13 Antiphospholipid Syndrome Conference Grant, National Heart, Lung, Blood Institute, NIH, 2016
ACR/EULAR Exchange Program Participant, 2015
HSS Academy of Rheumatology Medical Educator Award, 2015
Antiphospholipid Syndrome Research Award, New York Community Trust, 2012
Clinical & Translational Science Center Pilot Award, Cornell Medical College, 2011
Lupus Research Award, New York Community Trust, 2008
Rudd-Gardy Teaching Excellence Award, HSS Division of Rheumatology, 2008
Young Investigator Award, AESKU.KIPP Institute, Germany, 2007
Young Investigator Initiative Award, US Bone and Joint Decade, 2006
Antiphospholipid Syndrome Research Award, New York Community Trust, 2004
Dorothy W. Goldstein Young Scholar Award, Arthritis Foundation, New York Chapter, 2002
Rheumatology Fellow Award, American College of Rheumatology, 2001
Postdoctoral Fellowship Award, Arthritis Foundation, New York Chapter, 2001

Education

Medical Doctor (MD), Hacettepe University School of Medicine, Ankara, Turkey
Master of Public Health (MPH), Johns Hopkins University School of Public Health, Baltimore, Maryland

Residency

Internal Medicine, Beth Israel Medical Center, New York

Fellowship

Rheumatology, Hospital for Special Surgery, New York

State Licensure

Languages

English

Top 10 Series for Patients

Antiphospholipid Syndrome (APS) Terminology
APS Diagnosis Versus Classification
APS Clinical Research at HSS: 2023 Update
APS and Blood Clot Prevention
APS and the Gut Microbiome
APS and Skin Problems
APS and Organ Damage
APS and Lung Disease
APS and Cancer
APS in Children (Pediatric APS)
APS and Cognitive Dysfunction
APS and Pregnancy
APS and Potential New Treatments
APS and Surgical Procedures
APS ACTION International Clinical Database and Repository
Catastrophic APS
APS and COVID-19

Lupus Terminology
Lupus and Joint Involvement
Lupus, Osteopenia and Osteoporosis
Lupus and Blood Cell Disorders
Lupus and Heart Conditions
Lupus and Organ Damage
Lupus and Gender
Lupus and Pregnancy
Lupus and Cardiovascular Disease
Lupus and Autoimmune Thyroid Diseases

Other Patient Education Articles by Dr. Erkan

Lupus Research at Hospital for Special Surgery: An Introduction
Lupus and Radiation Treatment for Cancer, and Elective Cosmetic Procedures

Professional Education

• Management of Diffuse Peripheral Ischemia in Antiphospholipid Syndrome: Anticoagulation, Immunosuppression, Vasodilation, or All Three?

Selected Books/Chapters

Erkan D, Pierangeli SS (Editors). Antiphospholipid Syndrome: Insights and Highlights from the 13th International Congress on Antiphospholipid Antibodies. Springer, 2012.

Erkan D, Lockshin MD (Editors). Antiphospholipid Syndrome: Current Research Highlights and Clinical Insights. Springer, 2017.

The International Congress on Antiphospholipid Antibodies, held every 3 years, is the venue where representatives from different disciplines gather to discuss the recent advances in Antiphospholipid Syndrome (APS). The 15th Congress, chaired by Dr. Doruk Erkan, took place in September 2016. A novel aspect of the Congress was that multiple teams, chaired by Scientific Planning Committee members, used evidence-based literature reviews and expert discussions to answer specific pre-defined APS-related questions. The Scientific Planning Committee members also chaired the congress sessions and supervised completion of the reports that are the basis of the chapters of this most recent APS textbook. In addition, there are two chapters included specifically written for APS patients. This up-to-date and comprehensive work gathers invaluable insights from a multidisciplinary team of world-renowned experts and represents the authoritative resource on causes, symptoms, diagnosis, and treatment of APS.

Zuily S, Erkan D (Editors). Antiphospholipid Syndrome iBook for Medical Students. 2017.

The first APS digital book, a collaborative project between Hospital for Special Surgery and Nancy-Lorraine University, Nancy, France, is developed primarily to help medical students better understand the spectrum of aPL-related clinical problems and receive proper education in the diagnosis and management of APS. However, the authors hope that this APS digital book also will increase the awareness of APS among the medical community and patients.

 

For more publications, please see the PubMed listing and Google Scholar listing.

Dr. Doruk Erkan has been involved in Antiphospholipid Syndrome (APS) research since 1997. His research interest includes identification of factors that increase the risk of blood clots, potential prevention strategies, and new APS treatments. He is the principal investigator in multiple clinical trials ranging from mechanistic studies to drug trials for difficult-to-treat APS patients. He has been a member of multiple APS-related national/international committees as well as an invited speaker at numerous conferences. He is the founding member and Executive Committee Co-chair of the international APS research network, APS ACTION (Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking). More information about this network can be found at http://www.apsaction.org/.

Dr Erkan was the organization committee chair of the chaired 15th International Congress on Antiphospholipid Antibodies, which took place in September 2016. More information about this congress can be found at www.apsistanbul2016.org.

Dr Erkan is also one of the co-chairs of the International Society for Thrombosis and Hemostasis (ISTH) Scientific and Standardization Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies

Invited Special Lecture Presentations at International Scientific Meetings (Selected, 2011-2021 Only)

May 2011 – Antiphospholipid Syndrome Treatment Beyond Anticoagulation: Are We There Yet? The European League Against Rheumatism (EULAR) Scientific Annual Meeting, London, UK.

August 2011 – Primary Thrombosis Prophylaxis in Antiphospholipid Antibody Positive Patients. ReumaRio 2011 (National Brazil Rheumatology Meeting), Rio de Janeiro, Brazil.

August 2011 – Antiphospholipid Syndrome Management Beyond Anticoagulation. Are We There Yet? ReumaRio 2011 (National Brazil Rheumatology Meeting), Rio de Janeiro, Brazil.

October 2011 – Management of Antiphospholipid Syndrome.12th National Turkish Rheumatology Meeting, Antalya, Turkey.

November 2011 – APS ACTION. APS Study Group, American College of Rheumatology 75th Annual Scientific Meeting, Chicago, IL.

November 2011 – Clinical Symposium: Management of Antiphospholipid Syndrome, From Controversies to Consensus, Primary Thromboprophylaxis. American College of Rheumatology 75th Annual Scientific Meeting, Chicago, IL.

November 2012 – APS Study Group: APS ACTION - Two-year Anniversary, American College of Rheumatology Annual Scientific Meeting, Washington, DC.

November 2012 – Clinical Symposium: Catastrophic Antiphospholipid Syndrome. American College of Rheumatology Annual Scientific Meeting, Washington, DC.

April 2013 – Controversial Aspects of Antiphospholipid Syndrome. 3rd National Portugal Autoimmunity Meeting, Virtual Meet the Expert.

May 2013 – Antiphospholipid Syndrome Management Beyond Anticoagulation. 7th International Advances in Rheumatology Meeting, Santiago, Chile.

May 2013 – Catastrophic Antiphospholipid Syndrome: Where Do We Stand? 7th International Advances in Rheumatology Meeting, Santiago, Chile.

May 2013 – Cardiovascular Disease Prevention Strategies in Lupus and Antiphospholipid Syndrome. 7th International Advances in Rheumatology Meeting, Santiago, Chile.

September 2013 – Antiphospholipid Syndrome Treatment Trends Task Force Report & Recommendations, 14th International Congress on Antiphospholipid Antibodies and 4th Latin American Congress on Autoimmunity (APLA&LACA), Rio de Janeiro, Brazil.

September 2013 – Future of Antiphospholipid Syndrome Treatment. 14th International Congress on Antiphospholipid Antibodies and 4th Latin American Congress on Autoimmunity (APLA&LACA), Rio de Janeiro, Brazil.

October 2013 – Autoantibodies in Diagnosis and Follow-up Rheumatic Diseases Study Group: Improving Antiphospholipid Antibody Testing through International Collaboration (APS ACTION), American College of Rheumatology Annual Scientific Meeting, San Diego, CA.

October 2013 – Antiphospholipid Syndrome. American College of Rheumatology Annual Scientific Meeting Meet the Professor Session Speaker, San Diego, CA.

November 2013 – Meeting with the Professor – Antiphospholipid Syndrome Diagnosis and Treatment Dilemmas. XXVI Brazilian Congress of Rheumatology, Recife, Brazil.

November 2013 – New Perspectives in the Antiphospholipid Syndrome Treatment. XXVI Brazilian Congress of Rheumatology, Recife, Brazil.

March 2014 – Antiphospholipid Antibodies: What Do They Do & How Do They Do It? Advanced Rheumatology Symposium, Sao Paulo, Brazil.

March 2014 – Antiphospholipid Syndrome: New Treatment Perspectives. Advanced Rheumatology Symposium, Sao Paulo, Brazil.

November 2014 – Past, Present, and Future of Antiphospholipid Syndrome Task Forces. American College of Rheumatology Annual Scientific Meeting APS Study Group Speaker, Boston, MA.

December 2014 - Antiphospholipid Syndrome 2014 Update – Bookmarks in Rheumatology Symposium, Department of Clinical Sciences & Community Health- University of Milan, Milan, Italy.

December 2014 – Thrombosis Prophylaxis in Antiphospholipid Syndrome: Past, Present, and Future. University of Brescia, Rheumatology Grand Rounds, Brescia, Italy.

March 2015 - Antiphospholipid Syndrome. Turkish Hematology Association, Haemostasis Course, Istanbul, Turkey.

September 2015 – Cardiovascular Disease Prevention in Antiphospholipid Syndrome. 14th French Society of Vascular Medicine Annual Scientific Meeting, Nancy, France.

November 2015 - Antiphospholipid Syndrome. American College of Rheumatology Annual Scientific Meeting Meet the Professor Session Speaker, Boston, MA.

May 2016 – Antiphospholipid Syndrome. 24th Biennial International Congress on Thrombosis, Istanbul, Turkey.

April 2017 - Antiphospholipid Syndrome. American College of Rheumatology State of the Art Clinical Symposium (SOTA), Chicago, IL

July 2017 – Clinical Challenges Facing Antiphospholipid Syndrome Patients. International Society of Thrombosis and Hemostasis, Lupus Anticoagulant/Antiphospholipid Antibodies Subcommittee Session, Berlin, Germany.

July 2017 – Antiphospholipid Syndrome 2017 Update. International Society of Thrombosis and Hemostasis, Annual Scientific Meeting Abstract Session Opening Talk Speaker, Berlin, Germany.

October 2017 - Antiphospholipid Syndrome. American College of Rheumatology Annual Scientific Meeting Meet the Professor Session Speaker, San Diego, CA.

February 2018 – Masterclass: Antiphospholipid Syndrome – Management Principles. XVIII Work Congress of the International Union of Phlebology, Melbourne, Australia.

February 2018 – Management of Thromboembolism (Venous and Arterial) in Patients with Antiphospholipid Syndrome. XVIII Work Congress of the International Union of Phlebology, Melbourne, Australia.

February 2018 – State of Art Keynote Plenary: Update on Classification of Antiphospholipid Syndrome. XVIII Work Congress of the International Union of Phlebology, Melbourne, Australia.

July 2018 – Update on the New Antiphospholipid Syndrome Classification Criteria Development Efforts – ISTH LA/aPL Scientific Subcommittee Meeting, Dublin, Ireland.

July /2018 – Lupus Anticoagulant Panel Discussion – ISTH LA/aPL Scientific Subcommittee Meeting, Dublin, Ireland.

September 2018 – Antiphospholipid Syndrome 2018 Update. Turkish Rheumatology Society Annual Scientific Meeting, Bodrum, Turkey.

September 2018 – Antiphospholipid Syndrome Meet the Professor Session. Turkish Rheumatology Society Annual Scientific Meeting, Bodrum, Turkey.

October 2018 – Antiphospholipid Syndrome – Scary Stuff: Non-obstetric Stuff. Clinical Symposium, American College of Rheumatology Annual Scientific Meeting, Chicago, IL. 

September 2019 – Topics in Antiphospholipid Syndrome. 40th Harvard’s Advances in Rheumatology Course, Boston, MA.

September 2019 – Catastrophic Antiphospholipid Syndrome and Other Rare but Real APS Manifestations. 40th Harvard’s Advances in Rheumatology Course, Boston, MA.

September 2019 – Antiphospholipid Syndrome Definition and Emerging Clinical Phenotypes (Session: Clinical Manifestations Task Force). 16th International Congress on Antiphospholipid Antibodies, Manchester, UK.

September 2019 – Unmet Needs on Diagnosis and Management of Catastrophic Antiphospholipid Syndrome (Session: Catastrophic APS Task Force). 16th International Congress on Antiphospholipid Antibodies, Manchester, UK.

September 2019 – Antiphospholipid Syndrome Case Discussant (Session: Panic on the Streets of Manchester). 16th International Congress on Antiphospholipid Antibodies, Manchester, UK.

November 2019: The Art and Science of Antiphospholipid Syndrome (Session: Curbside Consult). American College of Rheumatology Annual Scientific Meeting, Atlanta, GA.

November 2019: Antiphospholipid Syndrome (Session: Meet the Professor). American College of Rheumatology Annual Scientific Meeting, Atlanta, GA.

December 2019 – Is there a Role for Immune Therapy in Antiphospholipid Syndrome (APS)? (Session: New Diagnostic and Treatment Strategies in APS). 61th American Society of Hematology Annual Meeting, Orlando, FL.

February 2021 – Update on the Management of Antiphospholipid Syndrome. Best of ACR Convergence 2020 – Emirates Rheumatology Academy Hybrid Meeting, Dubai (VIRTUAL)

May 2021 - Is there a Role for Immunosuppression in Antiphospholipid Syndrome? 11th International Course in Advances in Rheumatology, Clínica Alemana de Santiago, Santiago, Chile (VIRTUAL)

July 2021 – Update on the Management of Antiphospholipid Syndrome, 16th National Diagnosis Specification and Progress of Rheumatic Diseases Meeting Opening Talk, China (VIRTUAL) 

August 2021 – Primary Thrombosis Prevention Debate in Antiphospholipid Syndrome, Pan-American League of Rheumatology Associations (PANLAR) 2022 Meeting, Miami, FL (VIRTUAL)

November 2021 – Management of Challenging Cases in Antiphospholipid Syndrome, R365 Turkish Rheumatology Society e-symposium, Antalya, Turkey (VIRTUAL) 
 

Clinical Trials / Research Studies

• A 5-Year Prospective Observational Registry to Assess Adverse Events of Interest and Effectiveness in Adults with Active, Autoantibody-Positive Systemic Lupus Erythematosus Treated with or without BENLYSTA™ (belimumab)
• APS ACTION (Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking) International Clinical Database and Repository.
• Autoimmune Disease Registry and Repository

Patient Registries

• Dr. Erkan is a principal investigator for these patient registries.